Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23938365 | 0.78 | — | — | |
| SCHEMBL24729921 | 0.73 | — | — | |
| SCHEMBL23938167 | 0.72 | ALDH1A1 (0.34) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL19290505 | 0.70 | ALDH1A1 (0.34) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL21386186 | 0.70 | — | — | |
| SCHEMBL25036886 | 0.68 | — | — | |
| SCHEMBL23938048 | 0.67 | — | — | |
| SCHEMBL13866430 | 0.65 | MAPK1 (0.45) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL9032552 | 0.65 | ALDH1A1 (0.35) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL6888671 | 0.65 | MAPK1 (0.45) | ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11524966-B1 | Carboxamides as ubiquitin-specific protease inhibitors | VALO HEALTH, INC. (US) | 2022-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11524966-B1 | Carboxamides as ubiquitin-specific protease inhibitors | USP28, USP25, USP24 | ALDH1A1 2167/4885SMN1; SMN2 2918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.